GlassScriptPhysician profile
Heather Chalfin
NPI 1750652152
$10,028.54
in general payments reported to CMS, 2019-2025
19 companies · $7,370 in 2025
The $7,370 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.15 · 2023: $1,092 · 2024: $1,471 · 2025: $7,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,463 · Food and Beverage: $1,362 · Travel and Lodging: $73.56 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,463.00 |
| Food and Beverage | $1,361.77 |
| Travel and Lodging | $73.56 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $5,523.72 | 2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $1,415.17 | 2023-2024 | Orgovyx, Gemtesa |
| Janssen Scientific Affairs, LLC | $1,339.47 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $809.02 | 2023-2024 | |
| Immunitybio, INC. | $202.78 | 2025 | |
| Astellas Pharma US INC | $131.16 | 2023 | Padcev |
| Boston Scientific Corporation | $130.47 | 2025 | Spaceoar System, Axonics |
| Olympus America INC. | $95.01 | 2024 | Itind System, Olympus, Olympus |
| Teleflex LLC | $71.50 | 2022-2024 | Urolift |
| Intuitive Surgical, INC. | $63.60 | 2023 | Da Vinci Surgical System |
| Telix Pharmaceuticals | $53.07 | 2025 | Illuccix |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Photocure INC | $32.94 | 2022 | |
| Janssen Biotech, INC. | $23.62 | 2025 | Erleada |
| Merck Sharp & Dohme LLC | $23.30 | 2025 | Bridion |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $23.26 | 2025 | |
| Myriad Genetic Laboratories, INC. | $20.35 | 2022 | |
| Axonics, INC. | $19.44 | 2024 | Axonics |
| Coloplast Corp | $15.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Chalfin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.